10% holder buying at Avicanna (AVCN)

10% holder buying at Avicanna (T:AVCN)

Sheldon Inwentash, a 10% Holder, acquired 500,000 Common Shares on a control or direction basis for registered holder ThreeD Capital at a price of $0.350 on August 17th, 2022. This represents a $175,000 investment into the company's shares and an account share holdings change of 16.3%.

Avicanna is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Avicanna Inc. is a Canada-based commercial-stage biopharmaceutical company. The Company is engaged in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments. The Company's scientific platform commercializes over twenty products across four market segments: Medical Cannabis & Wellness Products, CBD Derma-Cosmetic Products, Pharmaceuticals and Cannabis Raw Materials, Seeds, and Bulk Formulations. Its Medical Cannabis & Wellness Products are an advanced line of pharmaceutical-grade cannabis products containing varying ratios of cannabidiol (CBD) and tetrahydrocannabinol (THC), marketed under the RHO Phyto brand. Its CBD Derma-Cosmetic Products are marketed under the Pura H&W or Pura Earth brands. Its cannabinoid-based drug candidates provide solutions for unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders.